Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2011, Article ID 381865, 6 pages
http://dx.doi.org/10.4061/2011/381865
Clinical Study

Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects

1Department of Cardiology and the Heart Failure Clinic, University Hospital of Larissa, University of Thessaly School of Medicine, Larissa, Greece
2Nuclear Medicine Unit, Hellenic Airforce (HAF) and Veterans Administration (VA) General Hospital, Athens, Greece
3Department of Internal Medicine, Hellenic Airforce (HAF) and Veterans Administration (VA) General Hospital, Athens, Greece
4Department of Endocrinology and Metabolic Diseases, University Hospital of Larissa, University of Thessaly School of Medicine, 41110 Larissa, Greece

Received 30 September 2010; Accepted 27 October 2010

Academic Editor: Georgios Giannakoulas

Copyright © 2011 Gregory Giamouzis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Smallridge, M. H. Goldman, K. Raines, S. Jones, and D. Van Nostrand, “Rest and exercise left ventricular ejection fraction before and after therapy in young adults with hyperthyroidism and hypothyroidism,” American Journal of Cardiology, vol. 60, no. 10, pp. 929–931, 1987. View at Google Scholar
  2. I. Klein and K. Ojamaa, “Thyroid hormone and the cardiovascular system,” New England Journal of Medicine, vol. 344, no. 7, pp. 501–509, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. M. Diekman, M. P. M. Harms, E. Endert, W. Wieling, and W. M. Wiersinga, “Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients,” European Journal of Endocrinology, vol. 144, no. 4, pp. 339–346, 2001. View at Google Scholar · View at Scopus
  4. W. H. Dillmann, “Biochemical basis of thyroid hormone action in the heart,” American Journal of Medicine, vol. 88, no. 6, pp. 626–630, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. G. A. Brent, “Mechanisms of disease: the molecular basis of thyroid hormone action,” New England Journal of Medicine, vol. 331, no. 13, pp. 847–853, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. I. Klein, K. Ojamaa, A. M. Samarel, R. Welikson, and C. Hong, “Hemodynamic regulation of myosin heavy chain gene expression: studies in the transplanted rat heart,” Journal of Clinical Investigation, vol. 89, no. 1, pp. 68–73, 1992. View at Google Scholar · View at Scopus
  7. A. J. de Bold, H. B. Borenstein, A. T. Veress, and H. Sonnenberg, “A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats,” Life Sciences, vol. 28, no. 1, pp. 89–94, 1981. View at Google Scholar · View at Scopus
  8. M. G. Currie, D. M. Geller, B. R. Cole et al., “Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria,” Science, vol. 221, no. 4605, pp. 71–73, 1983. View at Google Scholar · View at Scopus
  9. J. H. Laragh, “Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis,” New England Journal of Medicine, vol. 313, no. 21, pp. 1330–1340, 1985. View at Google Scholar · View at Scopus
  10. E. Rolandi, B. Santaniello, M. Bagnasco et al., “Thyroid hormones and atrial natriuretic hormone secretion: study in hyper- and hypothyroid patients,” Acta Endocrinologica, vol. 127, no. 1, pp. 23–26, 1992. View at Google Scholar · View at Scopus
  11. K. Widecka, J. Gozdzik, T. Dutkiewicz, U. Majewska, and S. Czekalski, “Atrial natriuretic factor in untreated hyperthyroidism,” Annals of Clinical Biochemistry, vol. 27, no. 4, pp. 313–317, 1990. View at Google Scholar · View at Scopus
  12. C. Parlapiano, E. Campana, N. Alessandri et al., “Plasma atrial natriuretic hormone in hyperthyroidism,” Endocrine Research, vol. 24, no. 1, pp. 105–112, 1998. View at Google Scholar
  13. G. Koukoulis, A. Polymeris, I. Tzavara, D. Pappas, and N. Thalassinos, “Normalization of thyroid hormone levels in patients with either hyper- or hypothyroidism results in a profound change of atrial natriuretic peptide (ANP) levels,” Hormones (Athens), vol. 1, no. 2, pp. 104–112, 2002. View at Google Scholar
  14. M. Kohno, K. Takaori, and T. Matsuura, “Atrial natriuretic polypeptide in atria and plasma in experimental hyperthyroidism and hypothyroidism,” Biochemical and Biophysical Research Communications, vol. 134, no. 1, pp. 178–183, 1986. View at Google Scholar
  15. P. W. Ladenson, K. D. Bloch, and J. G. Seidman, “Modulation of atrial natriuretic factor by thyroid hormone: messenger ribonucleic acid and peptide levels in hypothyroid, euthyroid, and hyperthyroid rat atria and ventricles,” Endocrinology, vol. 123, no. 1, pp. 652–657, 1988. View at Google Scholar · View at Scopus
  16. H. Matsubara, Y. Hirata, and H. Yoshimi, “Effects of steroid and thyroid hormones on synthesis of atrial natriuretic peptide by cultured atrial myocytes of rat,” Biochemical and Biophysical Research Communications, vol. 145, no. 1, pp. 336–343, 1987. View at Google Scholar · View at Scopus
  17. B. S. Edwards, R. S. Zimmerman, T. R. Schwab, D. M. Heublein, and J. C. Burnett Jr., “Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor,” Circulation Research, vol. 62, no. 2, pp. 191–195, 1988. View at Google Scholar · View at Scopus
  18. N. Katsube, D. Schwartz, and P. Needleman, “Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure,” Biochemical and Biophysical Research Communications, vol. 133, no. 3, pp. 937–944, 1985. View at Google Scholar · View at Scopus
  19. C. Cottier, L. Matter, P. Weidmann, S. Shaw, and M. P. Gnadinger, “Renal response to low-dose infusion of atrial natriuretic peptide in normal man,” Kidney International, vol. 34, no. 25, pp. S72–S78, 1988. View at Google Scholar · View at Scopus
  20. J. Anderson, A. Struthers, N. Christofides, and S. Bloom, “Atrial natriuretic peptide: an endogenous factor enhancing sodium excretion in man,” Clinical Science, vol. 70, no. 4, pp. 327–331, 1986. View at Google Scholar · View at Scopus
  21. P. Weidmann, B. Hellmueller, and D. E. Uehlinger, “Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man,” Journal of Clinical Endocrinology and Metabolism, vol. 62, no. 5, pp. 1027–1036, 1986. View at Google Scholar
  22. D. J. Sahn, A. DeMaria, J. Kisslo, and A. Weyman, “Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements,” Circulation, vol. 58, no. 6, pp. 1072–1083, 1978. View at Google Scholar · View at Scopus
  23. J. R. Dietz, “Release of natriuretic factor from rat heart-lung preparation by atrial distension,” The American Journal of Physiology, vol. 247, no. 6, pp. R1093–R1096, 1984. View at Google Scholar · View at Scopus
  24. R. E. Lang, H. Tholken, D. Ganten, F. C. Luft, H. Ruskoaho, and T. Unger, “Atrial natriuretic factor—a circulating hormone stimulated by volume loading,” Nature, vol. 314, no. 6008, pp. 264–266, 1985. View at Google Scholar · View at Scopus
  25. J. R. Ledsome, N. Wilson, C. A. Courneya, and A. J. Rankin, “Release of atrial natriuretic peptide by atrial distension,” Canadian Journal of Physiology and Pharmacology, vol. 63, no. 6, pp. 739–742, 1985. View at Google Scholar · View at Scopus
  26. C. H. Metzler, M. E. Lee, T. N. Thrasher, and D. J. Ramsay, “Increased right or left atrial pressure stimulates release of atrial natriuretic peptides in conscious dogs,” Endocrinology, vol. 119, no. 5, pp. 2396–2398, 1986. View at Google Scholar · View at Scopus
  27. S. Argentin, J. Drouin, and M. Nemer, “Thyroid hormone stimulates rat pro-natriodilatin mRNA levels in primary cardiocyte cultures,” Biochemical and Biophysical Research Communications, vol. 146, no. 3, pp. 1336–1341, 1987. View at Google Scholar · View at Scopus
  28. J. H. Oppenheimer, “Thyroid hormone action at the cellular level,” Science, vol. 203, no. 4384, pp. 971–979, 1979. View at Google Scholar · View at Scopus
  29. F. Pèronnet, R. J. Ferguson, H. Perrault, and G. Ricci, “Echocardiographic dimensions determined in normally active college women and in female athletes,” Medicine and Science in Sports and Exercise, vol. 14, no. 3, pp. 181–182, 1982. View at Google Scholar · View at Scopus
  30. C. P. Cheng, Y. Igarashi, and W. C. Little, “Mechanism of augmented rate of left ventricular filling during exercise,” Circulation Research, vol. 70, no. 1, pp. 9–19, 1992. View at Google Scholar · View at Scopus
  31. M. R. Curtois, B. Barzilai, Z. Vered, N. Ricciotti, and P. A. Ludbrook, “Effects of preload reduction on atrioventricular pressure relations and Doppler flow velocity,” Circulation, vol. 76, no. Sl, pp. IV–124, Abstract, 1987. View at Google Scholar
  32. P. V. Nguyen, D. L. Smith, and F. H. Leenen, “Acute volume loading, atrial natriuretic peptide release and cardiac function in healthy men. Effects of beta-blockade,” Life Sciences, vol. 43, no. 10, pp. 821–830, 1988. View at Google Scholar · View at Scopus
  33. S. K. Rerych, P. M. Scholz, D. C. Sabiston Jr., and R. H. Jones, “Effects of exercise training on left ventricular function in normal subjects: a longitudinal study by radionuclide angiography,” American Journal of Cardiology, vol. 45, no. 2, pp. 244–252, 1980. View at Google Scholar · View at Scopus
  34. E. F. Coyle, M. K. Hopper, and A. R. Coggan, “Maximal oxygen uptake relative to plasma volume expansion,” International Journal of Sports Medicine, vol. 11, no. 2, pp. 116–119, 1990. View at Google Scholar · View at Scopus
  35. M. K. Hopper, A. R. Coggan, and E. F. Coyle, “Exercise stroke volume relative to plasma-volume expansion,” Journal of Applied Physiology, vol. 64, no. 1, pp. 404–408, 1988. View at Google Scholar · View at Scopus
  36. I. L. Kanstrup and B. Ekblom, “Acute hypervolemia, cardiac performance, and aerobic power during exercise,” Journal of Applied Physiology Respiratory Environmental and Exercise Physiology, vol. 52, no. 5, pp. 1186–1191, 1982. View at Google Scholar · View at Scopus
  37. Y. Mori, M. Nishikawa, H. Matsubara et al., “Stimulation of rat atrial natriuretic peptide (rANP) synthesis by triiodothyronine and thyroxine (T4): T4 as a prohormone in synthesizing rANP,” Endocrinology, vol. 126, no. 1, pp. 466–471, 1990. View at Google Scholar · View at Scopus
  38. S. Czekalski, K. Widecka, J. Gozdzik et al., “Atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with thyrotoxicosis and atrial fibrillation. Effect of short-term methimazole therapy,” Journal of Endocrinological Investigation, vol. 17, no. 5, pp. 341–346, 1994. View at Google Scholar · View at Scopus
  39. G. Christensen and E. Leistad, “Atrial systolic pressure, as well as stretch, is a principal stimulus for release of ANF,” American Journal of Physiology, vol. 272, no. 2, pp. H820–H826, 1997. View at Google Scholar · View at Scopus
  40. J. C. Burnett Jr., M. J. Osborn, S. C. Hammill, and D. M. Heublein, “The role of frequency of atrial contraction versus atrial pressure in atrial natriuretic peptide release,” Journal of Clinical Endocrinology and Metabolism, vol. 69, no. 4, pp. 881–884, 1989. View at Google Scholar · View at Scopus